SavedAdd your journal

Journals / Erciyes Medical Journal / 2022 / Cilt: 44 - Sayı: 3

SARS CoV2 Variant Delta and Delta Plus, Molecular Change and Expected Impact of Response to COVID-19 Vaccine

Sora YASRİ
Viroj WİWANİTKİTi
Pages
353–354
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

YASRİ, S., WİWANİTKİTi, V. (2022). SARS CoV2 Variant Delta and Delta Plus, Molecular Change and Expected Impact of Response to COVID-19 Vaccine. Erciyes Medical Journal, Cilt: 44 - Sayı: 3, 353–354. https://ajindex.com/articles/502102

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Hsia W. Emerging new coronavirus infection in Wuhan, China: situation in early 2020. Case Study Case Rep 2020; 10(3): 8–9
  2. Hendaus MA, Jomha FA. Delta variant of COVID-19: A simple explanation. Qatar Med J 2021; 2021(3): 49
  3. Kannan SR, Spratt AN, Cohen AR, Naqvi SH, Chand HS, Quinn TP, et al. Evolutionary analysis of the Delta and Delta Plus variants of th e SARS-CoV-2 viruses. J Autoimmun 2021; 124: 102715
  4. Joob B, Wiwanitkit V. Methylenetetrahydrofolate reductase C677T polymorphism and diabetic retinopathy. Ophthalmic Genet 2018; 39: 414
  5. Joob B, Wiwanitkit V. New COVID-19 variant, VUI-202012/01: Its molecular change and implication for transmissibility. J Med Sci 2021;41:261.